ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,102Medicare Part D Prescriptions Filled, Including Refills

Rank: 72 out of 2035

$807K Total Retail Price of All Prescriptions

Rank: 90 out of 2035

895 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
10% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 895 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

8% of this provider’s 895 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 13,150 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
SIMVASTATIN 920 847 1 1
LEVOTHYROXINE SODIUM 786 743 2 4
LISINOPRIL 584 544 3 3
OMEPRAZOLE 517 486 4 5
ATENOLOL 454 451 5 10
AMLODIPINE BESYLATE 333 331 6 6
FLUTICASONE PROPIONATE 295 260 7 29
HYDROCODONE-ACETAMINOPHEN 283 194 S3 8 2
HYDROCHLOROTHIAZIDE 276 272 9 12
ATORVASTATIN CALCIUM 265 236 10 13
ZOLPIDEM TARTRATE 244 210 11 21
TRAMADOL HCL 236 229 12 19
WARFARIN SODIUM 233 233 13 11
METFORMIN HCL ER 229 205 14 78
METOPROLOL TARTRATE 227 223 15 8
FUROSEMIDE 221 217 16 7
LISINOPRIL-HYDROCHLOROTHIAZIDE 195 189 17 26
METOPROLOL SUCCINATE 191 190 18 16
PRAVASTATIN SODIUM 190 189 19 17
GABAPENTIN 184 174 20 14
ALENDRONATE SODIUM 170 170 21 27
PAROXETINE HCL 149 141 22 69
CITALOPRAM HBR 149 149 22 20
CARVEDILOL 147 134 24 22
TAMSULOSIN HCL 146 140 25 25
LOSARTAN POTASSIUM 142 142 26 15
LOVASTATIN 129 128 27 33
ALPRAZOLAM 120 110 28 109
DONEPEZIL HCL 112 108 29 24
POTASSIUM CHLORIDE 111 109 30 18
CLOPIDOGREL 109 108 31 30
LANTUS SOLOSTAR 107 99 32 66
GLIMEPIRIDE 106 93 33 55
METFORMIN HCL 101 96 34 9
NAPROXEN 94 88 35 92
NABUMETONE 91 77 36 190
CRESTOR 89 83 37 41
ALLOPURINOL 89 89 37 34
AZITHROMYCIN 88 79 39 39
ADVAIR DISKUS 86 82 40 38
EVISTA 86 86 40 136
LANSOPRAZOLE 85 58 42 118
PANTOPRAZOLE SODIUM 84 77 43 42
TRIAMTERENE-HCTZ 83 83 44 35
KLOR-CON M20 82 81 45 73
PREDNISONE 81 78 46 36
CIPROFLOXACIN HCL 74 73 47 63
SULFAMETHOXAZOLE-TRIMETHOPRIM 73 65 48 110
LOSARTAN-HYDROCHLOROTHIAZIDE 70 69 49 47
TRAZODONE HCL 65 65 50 50
PLAVIX 65 64 50 49
NOVOLOG FLEXPEN 63 52 52 133
PROAIR HFA 60 50 53 31
AMITRIPTYLINE HCL 59 53 R 54 101
CEPHALEXIN 58 54 55 91
ADACEL 57 53 56 253
BENAZEPRIL HCL 57 57 56 128
LORAZEPAM 56 50 58 219
ACTOS 55 54 59 124
JANUVIA 54 52 60 85
IBUPROFEN 52 45 61 43
FLUOXETINE HCL 51 51 62 81
VENLAFAXINE HCL ER 51 41 62 130
CELEBREX 51 39 62 104
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 22, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.